Abstract
We accomplished divergent synthesis of potent kinase inhibitor BAY 61-3606 (1) and 27 derivatives via conjugation of imidazo[1,2-c]pyrimidine and indole ring compounds with aromatic (including pyridine) derivatives by means of palladium-catalyzed cross-coupling reaction. Spleen tyrosine kinase (Syk) and germinal center kinase (Gck, MAP4K2) inhibition assays showed that some of the synthesized compounds were selective Gck inhibitors.
Keywords:
BAY 61-3606; Gck; Imidazo[1,2-c]pyrimidine; Indole; Kinase inhibitor.
Copyright © 2017 Elsevier Ltd. All rights reserved.
MeSH terms
-
Catalysis
-
Drug Evaluation, Preclinical
-
Germinal Center Kinases
-
Humans
-
Imidazoles / chemical synthesis
-
Imidazoles / chemistry*
-
Imidazoles / metabolism
-
Indoles / chemistry
-
Inhibitory Concentration 50
-
Niacinamide / analogs & derivatives
-
Niacinamide / chemistry
-
Niacinamide / metabolism
-
Palladium / chemistry
-
Protein Kinase Inhibitors / chemical synthesis*
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / metabolism
-
Protein Serine-Threonine Kinases / antagonists & inhibitors*
-
Protein Serine-Threonine Kinases / metabolism
-
Pyrimidines / chemical synthesis
-
Pyrimidines / chemistry*
-
Pyrimidines / metabolism
-
Structure-Activity Relationship
-
Syk Kinase / antagonists & inhibitors
-
Syk Kinase / metabolism
Substances
-
2-(7-(3,4-dimethoxyphenyl)imidazo(1,2-c)pyrimidin-5-ylamino)nicotinamide
-
Germinal Center Kinases
-
Imidazoles
-
Indoles
-
Protein Kinase Inhibitors
-
Pyrimidines
-
imidazo(1,2-c)pyrimidine
-
Niacinamide
-
Palladium
-
indole
-
Syk Kinase
-
Protein Serine-Threonine Kinases